Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit

Mar 30, 2020

|

NEW YORK — Rendu Biotechnology said on Monday that it has received emergency approval from China's National Medical Products Administration for a SARS-Cov-2 nucleic acid detection kit.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit

To read the full story....

Breaking News

AACC Issues Revised Guidance on Management of Point-of-Care Testing

In Brief This Week: Quest Diagnostics, Novacyt, Natera, and More

CDC Develops Test for Simultaneous Detection of COVID-19, Flu

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Immunovia Raises $43.0M Through Stock Issuance

Featured White Papers

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

Sponsorships